Corvus Pharmaceuticals is focused on the development of novel agents targeting the immune system to treat patients with cancer.
Business Model:
Revenue: $580k
Employees: 11-50
Address: 863 Mitten Road
City: Burlingame
State: CA
Zip: 94010
Country: US
Corvus Pharmaceuticals is focused on the development of novel agents targeting the immune system to treat patients with cancer.
Contact Phone:
+16509004520
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/23/2016
Ticker Symbol:
CRVS
IPO Price:
$14.6/share
Amount Raised:
$71M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Post-IPO Equity | $31.8M | 12/2014 | Series A | 1 | $33.5M |
OrbiMed OrbiMed OrbiMed OrbiMed |
9/2015 | Series B | 6 | $75M |
OrbiMed Adams Street Partners BlackRock Fidelity Management and Research Company Novo Ventures Rock Springs Capital Rock Springs Capital OrbiMed Adams Street Partners BlackRock Fidelity Management and Research Company Novo Ventures Rock Springs Capital Rock Springs Capital |
5/2021 | Post-IPO Equity | 2 | $10M |
EcoR1 Capital Richard A Miller EcoR1 Capital Richard A Miller |
11/2014 | Series A | $33.5M |
Adams Street Partners |
3/2016 | IPO | $71M | 3/2018 | Post-IPO Equity | $64.8M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|